Amid the severe shortage of vaccines across the country, the Centre on Thursday said the availability of vaccines would rise manifold by August with supplies flowing...
Indian regulators had granted regulatory approval or restricted use authorisation to Sputnik V on April 12. Sputnik V has an efficacy rate of 91.6 per cent....
The Indian drugs regulator, the Drugs Controller General of India (DCGI) has granted approval to indigenously developed Covid-19 vaccine Covaxin developed by Bharat Biotech for conducting...
The plant was functioning with 50 percent of the workforce on Thursday morning which included 19 regular company staff and 18 contractual labourers.
Several Congress leaders also countered the government on vaccine shortage after Urban Development Minister Hardeep Singh Puri had blamed Congress leaders for raising doubts about Bharat...
He said at least one of the locations is a major cremation spot for three districts, including Unnao, and that there was no confirmation these bodies...
Despite the Covid cases in the state are on decline, the Maharashtra government on Thursday extended the ongoing lockdown till June 1. The government imposed ‘Break...
The Hyderabad-based Bharat Biotech's indigenously developed Covaxin and Oxford-AstraZeneca's Covishield are currently being used in India's inoculation drive against coronavirus.
Several states and UTs including Delhi, Maharashtra, Karnataka and Telangana have decided to opt for global tenders for procurement of anti-coronavirus shots with the domestic supply...
Karnataka, with the country’s highest active caseload (5.87 lakh), administered just 74,015 doses; Kerala, with the third-highest active caseload (4.24 lakh), administered merely 771 doses.